Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amarin Corporation plc - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRN
Nasdaq
2830
www.amarincorp.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amarin Corporation plc
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
- Oct 9th, 2026 10:55 am
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
- Oct 9th, 2026 8:53 am
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
- Oct 9th, 2026 7:37 am
Here's Why You Should Add LPCN Stock to Your Portfolio Now
- Oct 8th, 2026 7:57 am
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
- Oct 7th, 2026 9:08 am
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
- Oct 1st, 2026 6:55 am
Teva's Branded Drugs Take Center Stage in Its Growth Strategy
- Sep 29th, 2026 5:50 am
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study
- Sep 17th, 2026 8:48 am
RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
- Sep 16th, 2026 8:56 am
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
- Sep 10th, 2026 9:30 am
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- Sep 9th, 2026 1:54 pm
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
- Aug 31st, 2026 6:15 am
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
- Aug 28th, 2026 6:15 am
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
- Aug 26th, 2026 9:13 am
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026
- Aug 24th, 2026 8:10 am
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
- Aug 24th, 2026 6:15 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
- Aug 12th, 2026 9:11 am
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
- Aug 12th, 2026 8:46 am
Amarin (AMRN) Q2 2026 Earnings Call Transcript
- Aug 7th, 2026 7:28 pm
Scroll